[1]
O. Khorshid and S. M. Ramadan, “EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS”, Mediterr J Hematol Infect Dis, vol. 7, no. 1, p. e2015058, Oct. 2015.